# Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer

> **NCT05830838** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 50 (actual)

## Conditions studied

- Malignant Prostate Neoplasm

## Interventions

- **PROCEDURE:** Computed Tomography
- **RADIATION:** Image-Guided Adaptive Radiation Therapy
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography
- **OTHER:** Questionnaire Administration
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT05830838
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-28
- **Primary completion:** 2028-05-30
- **Final completion:** 2029-05-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05830838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05830838, "Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05830838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*